| Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ... The Lancet Neurology 21 (3), 246-257, 2022 | 389 | 2022 |
| Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study A Manouchehrinia, CR Tench, J Maxted, RH Bibani, J Britton, ... Brain 136 (7), 2298-2304, 2013 | 234 | 2013 |
| Effect of smoking cessation on multiple sclerosis prognosis R Ramanujam, AK Hedström, A Manouchehrinia, L Alfredsson, T Olsson, ... JAMA neurology 72 (10), 1117-1123, 2015 | 219 | 2015 |
| Confounding effect of blood volume and body mass index on blood neurofilament light chain levels A Manouchehrinia, F Piehl, J Hillert, J Kuhle, L Alfredsson, T Olsson, ... Annals of clinical and translational neurology 7 (1), 139-143, 2020 | 201 | 2020 |
| Importance of early treatment initiation in the clinical course of multiple sclerosis A Kavaliunas, A Manouchehrinia, L Stawiarz, R Ramanujam, J Agholme, ... Multiple Sclerosis Journal 23 (9), 1233-1240, 2017 | 192 | 2017 |
| Age related multiple sclerosis severity score: disability ranked by age A Manouchehrinia, H Westerlind, E Kingwell, F Zhu, R Carruthers, ... Multiple Sclerosis Journal 23 (14), 1938-1946, 2017 | 161 | 2017 |
| Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios A Manouchehrinia, R Tanasescu, CR Tench, CS Constantinescu Journal of Neurology, Neurosurgery & Psychiatry 87 (3), 324-331, 2016 | 146 | 2016 |
| Blood neurofilament light levels segregate treatment effects in multiple sclerosis B Delcoigne, A Manouchehrinia, C Barro, P Benkert, Z Michalak, ... Neurology 94 (11), e1201-e1212, 2020 | 132 | 2020 |
| Towards personalized therapy for multiple sclerosis: prediction of individual treatment response T Kalincik, A Manouchehrinia, L Sobisek, V Jokubaitis, T Spelman, ... Brain 140 (9), 2426-2443, 2017 | 127 | 2017 |
| Long-term disability progression of pediatric-onset multiple sclerosis KA McKay, J Hillert, A Manouchehrinia Neurology 92 (24), e2764-e2773, 2019 | 112 | 2019 |
| Long-term cognitive outcomes in patients with pediatric-onset vs adult-onset multiple sclerosis KA McKay, A Manouchehrinia, L Berrigan, JD Fisk, T Olsson, J Hillert JAMA neurology 76 (9), 1028-1034, 2019 | 105 | 2019 |
| Rituximab in multiple sclerosis: frequency and clinical relevance of anti-drug antibodies N Dunn, A Juto, M Ryner, A Manouchehrinia, L Piccoli, K Fink, F Piehl, ... Multiple Sclerosis Journal 24 (9), 1224-1233, 2018 | 105 | 2018 |
| Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study S Binzer, KA McKay, P Brenner, J Hillert, A Manouchehrinia Neurology 93 (24), e2216-e2223, 2019 | 99 | 2019 |
| Locus for severity implicates CNS resilience in progression of multiple sclerosis MultipleMS Consortium Harroud Adil 1 78 78 Jónsdóttir Ingileif 74 75 Blanco ... Nature 619 (7969), 323-331, 2023 | 94 | 2023 |
| Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis A Manouchehrinia, P Stridh, M Khademi, D Leppert, C Barro, Z Michalak, ... Neurology 94 (23), e2457-e2467, 2020 | 85 | 2020 |
| Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis M Alrouji, A Manouchehrinia, B Gran, CS Constantinescu Journal of neuroimmunology 329, 24-34, 2019 | 83 | 2019 |
| Changes in the risk of reaching multiple sclerosis disability milestones in recent decades: a nationwide population-based cohort study in Sweden O Beiki, P Frumento, M Bottai, A Manouchehrinia, J Hillert JAMA neurology 76 (6), 665-671, 2019 | 81 | 2019 |
| Predicting risk of secondary progression in multiple sclerosis: a nomogram A Manouchehrinia, F Zhu, D Piani-Meier, M Lange, DG Silva, ... Multiple Sclerosis Journal 25 (8), 1102-1112, 2019 | 77 | 2019 |
| Clinical course of multiple sclerosis: a nationwide cohort study A Manouchehrinia, O Beiki, J Hillert Multiple Sclerosis Journal 23 (11), 1488-1495, 2017 | 70 | 2017 |
| Smoking and worsening disability in multiple sclerosis: A meta‐analysis P Heydarpour, A Manouchehrinia, O Beiki, SE Mousavi, A Abdolalizadeh, ... Acta Neurologica Scandinavica 138 (1), 62-69, 2018 | 65 | 2018 |
Jan HillertProfessor of neurology, Karolinska InstitutetVerified email at ki.se
